BALAXI PHARMACEUTICALS LIMITED (NSE:BALAXI) — Stock Price

Rs22.82 INR
▲ 0.40% today

BALAXI PHARMACEUTICALS LIMITED (NSE:BALAXI) is currently trading at Rs22.82 INR, up 0.40% today. Over the past 52 weeks, shares have ranged between Rs15.67 and Rs44.89. This page tracks BALAXI PHARMACEUTICALS LIMITED's live share price on the NSE exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see BALAXI company net worth.

BALAXI PHARMACEUTICALS LIMITED (BALAXI) Stock Price Chart — Daily History & Trading Volume

The chart below tracks BALAXI PHARMACEUTICALS LIMITED's daily closing share price and trading volume on the NSE exchange over the past year, giving a clear view of recent price momentum and liquidity.

BALAXI PHARMACEUTICALS LIMITED Income Statement — Revenue, Profit & Earnings by Year

BALAXI PHARMACEUTICALS LIMITED's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.

Fiscal Year 20262025202420232022
Total Revenue Rs2.73 Billion Rs2.89 Billion Rs2.41 Billion Rs3.36 Billion Rs2.79 Billion
Cost of Revenue Rs1.59 Billion Rs1.71 Billion Rs1.29 Billion Rs2.02 Billion Rs1.96 Billion
Gross Profit Rs1.14 Billion Rs1.27 Billion Rs1.13 Billion Rs1.34 Billion Rs837.91 Million
Research & Development — — Rs0.01 Rs0.17 Rs0.19
SG&A Rs725.79 Million Rs445.05 Million Rs277.95 Million Rs312.61 Million Rs131.41 Million
Total Operating Expenses Rs1.09 Billion Rs904.62 Million Rs656.74 Million Rs792.32 Million Rs334.80 Million
Operating Income Rs52.93 Million Rs363.99 Million Rs467.31 Million Rs586.30 Million Rs503.11 Million
EBITDA Rs74.45 Million Rs305.64 Million Rs456.59 Million Rs603.82 Million Rs560.20 Million
EBIT Rs52.93 Million Rs286.70 Million Rs435.60 Million Rs586.30 Million Rs555.08 Million
Interest Expense Rs39.04 Million Rs29.35 Million Rs16.77 Million Rs5.00 Million Rs1.42 Million
Income Before Tax Rs52.93 Million Rs286.70 Million Rs20.15 Million Rs569.22 Million Rs545.22 Million
Income Tax Expense Rs38.76 Million Rs35.99 Million Rs44.02 Million Rs109.60 Million Rs68.64 Million
Net Income Rs14.17 Million Rs250.70 Million Rs-23.87 Million Rs459.62 Million Rs476.58 Million

BALAXI PHARMACEUTICALS LIMITED Balance Sheet — Assets, Liabilities & Shareholder Equity

The balance sheet below summarizes BALAXI PHARMACEUTICALS LIMITED's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.

Fiscal Year 20262025202420232022
Total Assets Rs3.37 Billion Rs3.10 Billion Rs2.58 Billion Rs2.40 Billion Rs1.76 Billion
Total Current Assets Rs1.51 Billion Rs2.43 Billion Rs2.10 Billion Rs1.94 Billion Rs1.41 Billion
Cash & Equivalents — — — — Rs71.93 Million
Short-term Investments — Rs13.04 Million Rs1.00K Rs2.44 Billion Rs1.84 Million
Net Receivables Rs1.36 Billion Rs1.11 Billion Rs557.05 Million Rs522.82 Million Rs275.59 Million
Inventory Rs834.80 Million Rs784.81 Million Rs821.68 Million Rs1.05 Billion Rs987.04 Million
Property, Plant & Equipment — Rs363.11 Million Rs170.87 Million Rs190.16 Million Rs60.27 Million
Goodwill Rs326.71 Million Rs267.45 Million Rs261.00 Million Rs252.24 Million Rs233.02 Million
Total Liabilities Rs879.53 Million Rs786.06 Million Rs569.79 Million Rs567.89 Million Rs633.07 Million
Total Current Liabilities Rs334.37 Million Rs545.32 Million Rs541.97 Million Rs531.33 Million Rs632.68 Million
Long-term Debt Rs223.53 Million Rs212.45 Million Rs0.00 Rs8.70 Million Rs0.00
Net Debt Rs430.90 Million Rs140.26 Million Rs-428.87 Million Rs-149.10 Million Rs-35.55 Million
Total Stockholder Equity Rs2.49 Billion Rs2.32 Billion Rs2.01 Billion Rs1.83 Billion Rs1.13 Billion
Retained Earnings — Rs1.63 Billion Rs1.36 Billion Rs1.43 Billion Rs918.65 Million

BALAXI PHARMACEUTICALS LIMITED Cash Flow Statement — Operating, Investing & Financing Activities

This cash flow statement breaks down how BALAXI PHARMACEUTICALS LIMITED generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.

Fiscal Year 20262025202420232022
Operating Cash Flow Rs-82.44 Million Rs-377.82 Million Rs48.66 Million Rs60.75 Million Rs341.44 Million
Capital Expenditures Rs369.25 Million Rs211.19 Million Rs15.69 Million Rs149.80 Million Rs273.44 Million
Free Cash Flow Rs-451.69 Million Rs-589.01 Million Rs32.97 Million Rs-89.05 Million Rs68.00 Million
Investing Cash Flow Rs-207.79 Million Rs-217.64 Million Rs-10.46 Million Rs-105.65 Million Rs-284.48 Million
Financing Cash Flow Rs41.82 Million Rs366.55 Million Rs302.54 Million Rs255.13 Million Rs-1.63 Million
Dividends Paid — Rs0.00 — Rs4.98 Million Rs4.98 Million
Stock-Based Compensation — — — — —
Depreciation Rs21.53 Million Rs18.95 Million Rs20.98 Million Rs17.52 Million Rs5.12 Million
Change in Cash Rs-248.41 Million Rs-228.91 Million Rs340.74 Million Rs210.22 Million Rs55.33 Million

BALAXI PHARMACEUTICALS LIMITED Earnings History — EPS Actual vs. Analyst Estimates

Track BALAXI PHARMACEUTICALS LIMITED's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.

Report Date EPS Actual EPS Estimate Surprise
Jun 30, 2023 -40.49 — —
Dec 31, 2022 8.03 — —
Sep 30, 2022 15.49 — —
Jun 30, 2022 14.15 — —
Mar 31, 2022 12.71 — —
Feb 10, 2022 12.18 — —
Oct 28, 2021 12.05 — —
Jul 19, 2021 10.71 — —